Custom mRNA shot aims to stop liver cancer from coming back
NCT ID NCT07495215
First seen Apr 18, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study tests a personalized mRNA vaccine (iNeo-Vac-R01) made from a patient's own tumor, given together with an immunotherapy drug (PD-1 inhibitor) after liver cancer surgery. The goal is to train the immune system to destroy any remaining cancer cells and prevent the cancer from returning. About 20 adults with early-stage liver cancer who had successful surgery will participate. The treatment is designed to be precise and have fewer side effects than traditional therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital
RECRUITINGHangzhou, Zhejiang, 310016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.